Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) data-driven technology and solutions provider, is expected to report third quarter earnings results, after market close, on Tuesday 3rd November 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.04 per share.
Looking ahead, the full year income are expected at $ 0.22 per share on the revenues of $ 304.93 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 74.00 million ~ $ 78.00 million
Full Year 2020 topline are forecasted in a range of$ 300.00 million ~ $ 310.00 million
Click Here For More Historical Outlooks Of Tabula Rasa HealthCare, Inc.
Previous Quarter Performance
Tabula Rasa HealthCare, Inc. unfold income for the second quarter of $ 0.07 per share, from the revenue of $ 76.83 million. The quarterly earnings down 80.00 percent while revenues escalated 0.75 percent compared with the same quarter last year.
The consensus estimates are income of $ 0.06 per share from $ 78.09 million in revenue. The bottom line results beat street analysts by $ 0.01 or 16.67 percent, at the same time, top line results fell short of analysts by $ 1.26 million or 1.61 percent.
Stock Performance
Shares of Tabula Rasa HealthCare, Inc. traded low $ -0.49 or -1.42 percent on Monday, reaching $ 34.05 with volume of 243.60 thousand shares. Tabula Rasa HealthCare, Inc. has traded high as $ 35.30 and has cracked $ 33.53 on the downward trend
The closing price of $ 34.05, representing a 4.54 % increase from the 52 week low of $ 33.04 and a 50.46 % decrease over the 52 week high of $ 69.72.
The company has a market capital of $ 805.33 million and is part of the Technology sector and Health Information Services industry.
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The companys proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks.
